Core Viewpoint - The announcement details the pledge of shares by a major shareholder of Wuhan Heyuan Biotechnology Co., Ltd., indicating a significant portion of their holdings has been pledged as collateral for financial purposes [2]. Group 1: Shareholder Information - As of the announcement date, Shanghai Tongsheng Yongying Enterprise Management Center (Limited Partnership) holds 20,084,400 shares of the company, accounting for 5.62% of the total share capital [2]. - The shareholder has pledged 11,730,000 shares, which represents 58.40% of their total holdings and 3.28% of the company's total share capital [2]. Group 2: Pledge Details - The pledged shares are not being used as collateral for major asset restructuring or performance compensation, and there are no potential performance compensation obligations associated with these shares [2]. - The cumulative pledged shares by the shareholder, as of the announcement date, total 11,730,000 shares, maintaining the same percentage of their holdings and the company's total share capital [2]. Group 3: Disclosure Commitment - The company commits to timely information disclosure should there be any significant changes regarding the pledged shares [2].
武汉禾元生物科技股份有限公司关于持股5%以上股东部分股份质押的公告